<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="206950">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00394290</url>
  </required_header>
  <id_info>
    <org_study_id>IJL-PPC-EP02</org_study_id>
    <secondary_id>Morphee</secondary_id>
    <nct_id>NCT00394290</nct_id>
  </id_info>
  <brief_title>Down Syndrome and Continuous Positive Pressure Therapy</brief_title>
  <acronym>Morphee</acronym>
  <official_title>Follow-up of the Therapeutic Coverage by Continuous Positive Pressure of the Obstructive Sleep Apnea Syndrome for Down Syndrome Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Jerome Lejeune</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondation Jérôme Lejeune</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut Jerome Lejeune</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and tolerability of Continuous
      Positive Pressure for SAOS in Down Syndrome patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2006</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Scores on psychometrical and dementia scales after a 3-month treatment period (and if possible, after 12 months)</measure>
    <time_frame>0 and 3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerability</measure>
    <time_frame>0, 3 and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Down Syndrome</condition>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <arm_group>
    <arm_group_label>PPC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Night time device for positive pulmonary pressure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous Positive Pressure</intervention_name>
    <description>Nighttime continuous positive pressure device, to be used every day</description>
    <arm_group_label>PPC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Down Syndrome patients with an Obstructive Sleep Apnea Syndrome

          -  more than 18 years old

        Exclusion Criteria:

          -  predictable non-compliance of device

          -  non-compensated cardiopathy

          -  non-stable thyroxin treatment

          -  non-stable diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martine Conte, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Jerome Lejeune</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Franck STURTZ, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Institut Jerome Lejeune</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yann Grattau, M.D.</last_name>
    <phone>+33 1 56586325</phone>
    <email>yann.grattau@institutlejeune.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Celine duBoispean</last_name>
    <phone>+33 1 56586328</phone>
    <email>celine.du.boispean@institutlejeune.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut Jerome Lejeune</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yann Grattau, M.D.</last_name>
      <phone>+33 1 56586325</phone>
      <email>yann.grattau@institutlejeune.org</email>
    </contact>
    <contact_backup>
      <last_name>Celine duBoispean</last_name>
      <phone>+33 1 56586328</phone>
      <email>celine.du.boispean@institutlejeune.org</email>
    </contact_backup>
    <investigator>
      <last_name>Martine Conte, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Resta O, Barbaro MP, Giliberti T, Caratozzolo G, Cagnazzo MG, Scarpelli F, Nocerino MC. Sleep related breathing disorders in adults with Down syndrome. Downs Syndr Res Pract. 2003 Aug;8(3):115-9.</citation>
    <PMID>14502839</PMID>
  </reference>
  <verification_date>October 2012</verification_date>
  <lastchanged_date>October 18, 2012</lastchanged_date>
  <firstreceived_date>October 31, 2006</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Down Syndrome</keyword>
  <keyword>Obstructive Sleep Apnea Syndrome</keyword>
  <keyword>Continuous Positive Pressure</keyword>
  <keyword>Hypersomnia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Down Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
